Interferon‐α/β–mediated innate immune mechanisms in dermatomyositis
暂无分享,去创建一个
G. Pinkus | S. Greenberg | D. Sanoudou | R. Barohn | M. Ericsson | R. Tawil | A. Amato | H. Briemberg | J. Pinkus | T. Burleson | D. Saperstein | P. Park | Peter Park
[1] S. Greenberg,et al. Uncertainties in the pathogenesis of adult dermatomyositis , 2004, Current opinion in neurology.
[2] R. Hughes,et al. 119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands , 2004, Neuromuscular Disorders.
[3] G. Borm,et al. Diagnostic value of MHC class I staining in idiopathic inflammatory myopathies. , 2004, Journal of neurology, neurosurgery, and psychiatry.
[4] C. Bao,et al. Protein interaction for an interferon-inducible systemic lupus associated gene, IFIT1. , 2003, Rheumatology.
[5] M. Crow. Interferon-α: A new target for therapy in systemic lupus erythematosus? , 2003 .
[6] C. Bao,et al. Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray , 2003, Genes and Immunity.
[7] J. Hardin. Directing Autoimmunity to Nucleoprotein Particles , 2003, The Journal of experimental medicine.
[8] Virginia Pascual,et al. Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood , 2003, The Journal of experimental medicine.
[9] G. Karypis,et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[10] M. Crow. Interferon-alpha: a new target for therapy in systemic lupus erythematosus? , 2003, Arthritis and rheumatism.
[11] L. Rönnblom,et al. The natural interferon-α producing cells in systemic lupus erythematosus , 2002 .
[12] C. Angelini,et al. Muscle pathology in dysferlin deficiency , 2002, Neuropathology and applied neurobiology.
[13] L. Kunkel,et al. Molecular profiles of inflammatory myopathies , 2002, Neurology.
[14] G. Kochs,et al. Interferon‐Induced Mx Proteins: Dynamin‐Like GTPases with Antiviral Activity , 2002, Traffic.
[15] M. McNiven,et al. The Antiviral Dynamin Family Member, MxA, Tubulates Lipids and Localizes to the Smooth Endoplasmic Reticulum* , 2002, The Journal of Biological Chemistry.
[16] Eric P. Hoffman,et al. Gene Expression Profiling in DQA1*0501+ Children with Untreated Dermatomyositis: A Novel Model of Pathogenesis1 , 2002, The Journal of Immunology.
[17] M. Dalakas,et al. Inclusion body myositis and myopathies , 1997, Journal of the Neurological Sciences.
[18] L. Rönnblom,et al. The natural interferon-alpha producing cells in systemic lupus erythematosus. , 2002, Human immunology.
[19] L. Rönnblom,et al. Importance of CpG Dinucleotides in Activation of Natural IFN‐α‐Producing Cells by a Lupus‐Related Oligodeoxynucleotide , 2001, Scandinavian journal of immunology.
[20] F. Lund-Johansen,et al. Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. , 2001, The American journal of pathology.
[21] S. Miltenyi,et al. BDCA-2, BDCA-3, and BDCA-4: Three Markers for Distinct Subsets of Dendritic Cells in Human Peripheral Blood , 2000, The Journal of Immunology.
[22] G. Sturfelt,et al. Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies , 2000, Lupus.
[23] S. Goodbourn,et al. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. , 2000, The Journal of general virology.
[24] Andrew G. Engel,et al. αB-Crystallin immunolocalization yields new insights into inclusion body myositis , 2000, Neurology.
[25] B. Banwell,et al. AlphaB-crystallin immunolocalization yields new insights into inclusion body myositis. , 2000, Neurology.
[26] N. Kadowaki,et al. The nature of the principal type 1 interferon-producing cells in human blood. , 1999, Science.
[27] B. Williams,et al. Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays , 1998 .
[28] B. Williams,et al. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[29] C. Magro,et al. The immunofluorescent profile of dermatomyositis: a comparative study with lupus erythematosus , 1997, Journal of cutaneous pathology.
[30] I. Illa,et al. Signal transducer and activator of transcription 1 in human muscle: implications in inflammatory myopathies. , 1997, The American journal of pathology.
[31] C. Janeway. Immunobiology: The Immune System in Health and Disease , 1996 .
[32] P. Tempst,et al. Purification, Microsequencing, and Immunolocalization of p36, a New Interferon-α-induced Protein That Is Associated with Human Lupus Inclusions (*) , 1996, The Journal of Biological Chemistry.
[33] S. Pillai,et al. Innate immunity. , 1996, Current opinion in immunology.
[34] R. Steinman,et al. Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium , 1993, The Journal of experimental medicine.
[35] H. Hochkeppel,et al. The interferon-induced Mx-homologous protein in people with symptomatic HIV-1 infection. , 1990, AIDS.
[36] A. Engel,et al. Immune effector mechanisms in inflammatory myopathies. , 1990, Research publications - Association for Research in Nervous and Mental Disease.
[37] P. Grimley,et al. Cultured human endothelial cells treated with recombinant leukocyte A interferon. Tubuloreticular inclusion formation, antiproliferative effect, and 2',5' oligoadenylate synthetase induction. , 1988, Laboratory investigation; a journal of technical methods and pathology.
[38] J. Orenstein,et al. The relationship of serum alpha-interferon and ultrastructural markers in HIV-seropositive individuals. , 1987, Ultrastructural pathology.
[39] S. Rich,et al. Induction of lupus inclusions by sera from patients with systemic lupus erythematosus. , 1986, Arthritis and rheumatism.
[40] J. Mendell,et al. Microvascular deposition of complement membrane attack complex in dermatomyositis. , 1986, The New England journal of medicine.
[41] J. Hoofnagle,et al. Tubuloreticular inclusions in peripheral blood mononuclear cells related to systemic therapy with alpha-interferon. , 1985, Laboratory investigation; a journal of technical methods and pathology.
[42] A. Engel,et al. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells , 1984, Annals of neurology.
[43] J. Deruaz,et al. [The pathology of skeletal muscle]. , 1981, Revue medicale de la Suisse romande.
[44] S. Rich. Human lupus inclusions and interferon. , 1981, Science.
[45] A. Eisen,et al. Experimental ischemic myopathy. , 1974, Journal of the neurological sciences.
[46] W. Engel,et al. Experimental myopathy after microarterial embolization; comparison with childhood x-linked pseudohypertrophic muscular dystrophy. , 1970, Archives of neurology.
[47] W. L. Norton,et al. Endothelial inclusions in dermatomyositis. , 1970, Annals of the rheumatic diseases.
[48] Robert G. Cooper,et al. Polymyositis and Dermatomyositis , 2022 .
[49] Norton Wl. Endothelial inclusions in active lesions of systemic lupus erythematosus. , 1969 .
[50] W. Norton. Endothelial inclusions in active lesions of systemic lupus erythematosus. , 1969, The Journal of laboratory and clinical medicine.